Supernus Pharmaceuticals (SUPN) Revenue (2011 - 2026)
Supernus Pharmaceuticals (SUPN) revenue from Mar 31, 2011 to Mar 31, 2026. The TTM Supernus Pharmaceuticals (SUPN) revenue is $777M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Supernus Pharmaceuticals (SUPN) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +16.29% |
| 3 Years TTM | +5.13% |
| 5 Years TTM | +6.90% |
| 10 Years TTM | +20.96% |
| All Time TTM | +60.75% |
Annual Revenue change of Supernus Pharmaceuticals (SUPN)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $208M | -71.11% |
| 2025 | $719M | +8.63% |
| 2024 | $662M | +8.94% |
| 2023 | $608M | -8.95% |
| 2022 | $667M | +15.09% |
| 2021 | $580M | +11.41% |
| 2020 | $520M | +32.50% |
| 2019 | $393M | -3.95% |
| 2018 | $409M | +39.03% |
| 2017 | $294M | +39.99% |
| 2016 | $210M | +46.37% |
| 2015 | $144M | +60.24% |
| 2014 | $90M | +767.09% |
| 2013 | $10M | +597.97% |
| 2012 | $1.48M | +85.00% |
| 2011 | $800K | +627.27% |
| 2010 | $110K | N/A |
Comparison Supernus Pharmaceuticals (SUPN) five years revenue CAGR with competitors
Supernus Pharmaceuticals (SUPN) five years revenue CAGR is 6.90%.